[Acceptance of the vaccine against human papilloma virus from mothers to daughters aged 9 to 13 years old].
BACKGROUND
If you consider that at some point in life 50% of sexually active women have had an infection with the human papilloma virus is indisputable that any attempt to reduce the prevalence worth undertaking it. The vaccine to prevent HIV infection has not enjoyed the same degree of acceptance than others, hence the interest in knowing some of the reasons that has not achieved universal vaccination.


OBJECTIVE
To examine human papillomavirus (HPV) vaccine acceptability among mothers with adolescents girls between 9 and 13 years old.


METHODS
The mothers were interrogated about HVP vaccine acceptability, reasons provided for acceptance or non-acceptance and if mothers know that vaccine is offered free for public health institutions


RESULTS
We interview a 250 mothers with 281 daughters, 38 daughters have already received the vaccine. Eighty nine percent of the mothers reacted positively to the possibility of vaccinating theirs daughters. The reasons of vaccine non-acceptance were because not knowing enough about infection, mother felt that their daughters were not at risk for acquiring HVP infection, the vaccine is new and mothers unknown side effects. Thirty nine percent of the mothers want to know more about the vaccine safety, 21% about length protection duration and 16% concerning about if the vaccine is effective. Fifty seven per cent of the mothers know that Health Secretary offers vaccine free. Mothers whom have been vaccinated their daughters, had daughters with lower age (9.8 +/- 0.9 vs 10.8 +/- 1.3 years, p = 0.0001), were more frequently married (79 vs 51%, p = 0.002) and more likely to report that they had heard about VPH vaccine from some source (100 vs 66%, p = 0.0001) that mothers have not yet vaccinated their daughters.


CONCLUSIONS
The acceptability of VPH vaccine was 89%. Continued health education and propaganda is needed to promote a better knowledge of VPH vaccine.
Unidad de Medicina Familiar 27, IMSS, Tijuana, BC.
Melissa Karina
MK
Godoy Verdugo
Unidad de Investigación Clínica y Epidemiología, Hospital General Regional 20, IMSS Tijuana, BC.
Abraham
A
Zonana Nacach
Coordinación Clinica de Enseñanaza e Investigación, Unidad de Medicina Familiar 27, IMMS, Tijuana, BC.
Maria Cecilia
MC
Anzaldo Campos
D000293:Adolescent; D000328:Adult; D001294:Attitude to Health; D002648:Child; D005260:Female; D006801:Humans; D009035:Mothers / Q000523:psychology*; D009679:Nuclear Family; D053918:Papillomavirus Vaccines; D010342:Patient Acceptance of Health Care; D012189:Retrospective Studies; D011795:Surveys and Questionnaires
D053918:Papillomavirus Vaccines